Levetiracetam Uses, Dosage, Side Effects and Interactions
Elepsia XR
Elepsia XR came 19 years after Keppra (December 2018) as an extended-release tablet. An FDA-approved generic with the same active ingredient is listed.
Keppra
Keppra was the first levetiracetam product the FDA approved, in November 1999. An FDA-approved generic with the same active ingredient is listed.
Keppra XR
Keppra XR came 8 years after Keppra (September 2008). An FDA-approved generic with the same active ingredient is listed.
Spritam
Spritam came 15 years after Keppra (July 2015) as a tablet. The FDA rates no generic as a substitute for it.
Roweepra
Roweepra is a brand of levetiracetam that comes as a tablet. An FDA-approved generic with the same active ingredient is listed.
Levetiracetam is an antiseizure medicine used for partial-onset seizures, and as add-on treatment for myoclonic seizures in juvenile myoclonic epilepsy and primary generalized tonic-clonic seizures in idiopathic generalized epilepsy, in oral and intravenous forms.
Quick links
Ask Anything About LevetiracetamType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Levetiracetam in Short
What it treatsLevetiracetam treats partial-onset seizures (seizures that start in one area of the brain). Immediate-release tablets, oral solution and injection (such as Keppra) are labeled for ages 1 month and older. Extended-release tablets (Keppra XR, Levetiracetam ER) are for ages 12 and older.
- How you get it Prescription only
- Comes asTablet, injection, extended-release tablet and oral solutionAvailable strengths
Tablet (by mouth)
- 250 mg
- 500 mg
- 750 mg
- 1000 mg
Injection (into a vein)
- 500 mg/5 mL
- 500 mg/100 mL
See forms and strengths+ 7 more strengthsShow fewer strengths
Injection (into a vein)
- 1000 mg/100 mL
- 1500 mg/100 mL
Extended-release tablet (by mouth)
- 500 mg
- 750 mg
- 1000 mg
- 1500 mg
Oral solution (by mouth)
- 100 mg/mL
- Crushing or chewingSome forms are on our Do Not Crush list Listed: Elepsia XR (tablet, extended release); Keppra (tablet, film coated); and 2 more
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- Supplements and herbs104 interact 7 major, 81 moderate and 16 minor
- What pharmacies pay
- Generic$0.06 to $0.17 a tablet
- Brand names$8.08 to $10.27 a tabletKeppra and Spritam
- Injections: no national price found
The pharmacy’s own cost, national average. Not your price See every price+ 4 more price detailsShow fewer price details
- Extended-release tablets, generic: $0.18 to $0.25 each
- Extended-release tablets, Keppra: $9.00 to $13.48 each
- Oral solution, generic: $0.03 per mL
- Oral solution, Keppra: $1.92 per mL
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Levetiracetam (Keppra) is one of the most widely prescribed antiseizure medicines, often a first choice for partial-onset seizures (those that start in one area of the brain) and an add-on for some generalized seizures; it seems to work by binding SV2A, a nerve-cell protein that helps control chemical signaling, and it has been on the U.S. market since about 1999, with FDA-approved generics listed. Most people tolerate it well, and sleepiness, tiredness and dizziness are what they usually notice, often easing over the first few weeks. Watch for irritability, aggression (more common in children), depression or suicidal thoughts, and report any new mood change promptly.
Key Takeaways From the HelloPharmacist Team
- Expect to take it twice a day (extended-release once a day, swallowed whole), with the dose usually raised every 2 weeks.
- Never stop it suddenly or let a refill lapse, because stopping abruptly can bring on more seizures.
- Hold off on driving or using machinery until you know how much sleepiness or unsteadiness it causes you.
- Call your doctor at the first sign of a rash, and get emergency care for swelling of the lips, tongue or throat.
Patient Information Guide for Levetiracetam
What It’s Used For
Levetiracetam is an antiseizure medicine with several approved uses, depending on the product.
- Partial-onset seizures: Keppra, Roweepra and other immediate-release tablets, oral solution and injection are labeled from 1 month of age. Spritam is labeled for ages 4 and older weighing over 20 kg.
- Partial-onset seizures: Keppra XR and Levetiracetam ER are labeled for ages 12 and older. Elepsia XR is labeled as add-on therapy for ages 12 and older.
- Add-on therapy for myoclonic seizures in juvenile myoclonic epilepsy, ages 12 and older (immediate-release oral products, Spritam and injection).
- Add-on therapy for primary generalized tonic-clonic seizures in idiopathic generalized epilepsy, ages 6 and older (immediate-release oral products, Spritam and injection).
- Injection: only when oral use is temporarily not feasible. Levetiracetam in Sodium Chloride injection is labeled for adults 16 and older.
How It Works
The exact way levetiracetam prevents seizures is unknown. It binds to a protein called SV2A on nerve cells, which is thought to help control the release of chemical messengers between nerves.
In animal studies, how strongly similar compounds bound to SV2A matched their antiseizure strength. This suggests the binding may play a role.
Drug Class
What It Does in the Body
- Decreased Central Nervous System Disorganized Electrical Activity
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)None listed for Levetiracetam in the FDA’s index.
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)None listed for Levetiracetam in the FDA’s index.
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)- Decreased Central Nervous System Disorganized Electrical Activity
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)None listed for Levetiracetam in the FDA’s index.
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Other antiepileptics
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Levetiracetam comes as tablets, oral solution, extended-release tablets and an injection. Always follow your prescriber's directions and the product label.
- Immediate-release tablets and oral solution are usually taken by mouth twice daily.
- Extended-release tablets are taken once daily and swallowed whole.
- The injection is given into a vein over about 15 minutes by a healthcare professional.
- Doses usually start low and increase gradually. Kidney function can change the dose.
- Don't stop suddenly. Ask your pharmacist or doctor what to do about a missed dose.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Levetiracetam Tablets and Oral Solution
Partial-onset seizures
Adults 16 years and older Starting dose 500 mg twice a day Usual dose 1500 mg twice a day Highest dose 3000 mg a day
- Increase by 500 mg twice daily every 2 weeks to a recommended dose of 1500 mg twice daily
Children 1 month to less than 6 months old Starting dose 7 mg/kg twice a day Usual dose 21 mg/kg twice a day
- Increase by 7 mg/kg twice daily every 2 weeks to recommended dose of 21 mg/kg twice daily
Good to know
Use oral solution for weight 20 kg or less
Children 6 months to less than 4 years old Starting dose 10 mg/kg twice a day Usual dose 25 mg/kg twice a day
- Increase by 10 mg/kg twice daily every 2 weeks to recommended dose of 25 mg/kg twice daily
Good to know
Use oral solution for weight 20 kg or less
Children 4 to less than 16 years old Starting dose 10 mg/kg twice a day Usual dose 30 mg/kg twice a day
- Increase by 10 mg/kg twice daily every 2 weeks to recommended dose of 30 mg/kg twice daily
Good to know
Use oral solution for weight 20 kg or less
Myoclonic seizures in juvenile myoclonic epilepsy
For adults and children 12 years and older
Starting dose 500 mg twice a day
Usual dose 1500 mg twice a day
- Increase by 500 mg twice daily every 2 weeks to recommended dose of 1500 mg twice daily
Primary generalized tonic-clonic seizures
Adults 16 years and older Starting dose 500 mg twice a day Usual dose 1500 mg twice a day
- 500 mg twice daily, increase by 500 mg twice daily every 2 weeks to recommended dose of 1500 mg twice daily
Children 6 to less than 16 years old Starting dose 10 mg/kg twice a day Usual dose 30 mg/kg twice a day
- 10 mg/kg twice daily, increase in increments of 10 mg/kg twice daily every 2 weeks to recommended dose of 30 mg/kg twice daily
Kidney problems, normal (CLcr > 80 mL/min/1.73m2)
For adults
Dose 500 to 1,500 mg every 12 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Kidney problems, mild (CLcr 50 – 80 mL/min/1.73m2)
For adults
Dose 500 to 1,000 mg every 12 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Kidney problems, moderate (CLcr 30 – 50 mL/min/1.73m2)
For adults
Dose 250 to 750 mg every 12 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Kidney problems, severe (CLcr < 30 mL/min/1.73m2)
For adults
Dose 250 to 500 mg every 12 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Adults with kidney failure (ESRD) using
For adults on dialysis
Usual dose 250 to 500 mg
Step by step
- 500 to 1,000 mg every 24 hours
- Following dialysis, a 250 to 500 mg supplemental dose is recommended
ESRD means end-stage renal disease (kidney failure).
Levetiracetam Extended-Release Tablets
Seizures (extended-release tablets)
For adults and teens 12 years and older weighing 50 kg or more
Starting dose 1,000 mg once a day
Highest dose 3,000 mg once a day
Step by step
- Initiate 1,000 mg once daily
- Increase by 1,000 mg every 2 weeks
Extended-release tablets, with normal kidney function (CLcr > 80)
For adults
Dose 1,000 to 3,000 mg every 24 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Extended-release tablets, with mild kidney problems (CLcr 50 - 80)
For adults
Dose 1,000 to 2,000 mg every 24 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Extended-release tablets, with moderate kidney problems (CLcr 30 - 50)
For adults
Dose 500 to 1,500 mg every 24 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Extended-release tablets, with severe kidney problems (CLcr < 30)
For adults
Dose 500 to 1,000 mg every 24 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Spritam
Partial-onset seizures
For adults and children weighing over 40 kg
Starting dose 500 mg twice a day
Highest dose 1,500 mg twice a day
Step by step
- 500 mg twice daily (1,000 mg daily)
- Increase by 500 mg twice daily every 2 weeks
Myoclonic and primary generalized tonic-clonic seizures
For adults and children weighing over 40 kg
Starting dose 500 mg twice a day
Usual dose 1,500 mg twice a day
Step by step
- 500 mg twice daily (1,000 mg daily)
- Increase by 500 mg twice daily every 2 weeks to recommended 1,500 mg twice daily (3,000 mg daily)
These are the doses for children. For adults, see “Partial-onset seizures.”
Seizures (Spritam)
For children weighing 20 kg to 40 kg
Starting dose 250 mg twice a day
Highest dose 750 mg twice a day
Step by step
- 250 mg twice daily (500 mg daily)
- Increase by 250 mg twice daily every 2 weeks
Spritam, with normal kidney function (CLcr >80)
For adults
Dose 500 to 1,500 mg every 12 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Spritam, with mild kidney problems (CLcr 50-80)
For adults
Dose 500 to 1,000 mg every 12 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Spritam, with moderate kidney problems (CLcr 30-50)
For adults
Dose 250 to 750 mg every 12 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Spritam, with severe kidney problems (CLcr <30)
For adults
Dose 250 to 500 mg every 12 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Spritam, adults with kidney failure (ESRD) using
For adults on dialysis
Usual dose 250 to 500 mg
Step by step
- 500 to 1,000 mg every 24 hours
- Following dialysis, a 250 to 500 mg supplemental dose is recommended
ESRD means end-stage renal disease (kidney failure).
Levetiracetam Injection
Partial-onset seizures
Injection, partial-onset seizures Starting dose 500 mg twice a day Highest dose 1,500 mg twice a day
- Increase by 500 mg twice daily every 2 weeks
Good to know
Given as a 15-minute infusion; not diluted
Adults 16 years and older · Keppra 500 mg Starting dose 500 mg twice a day Usual dose 1,500 mg twice a day Highest dose 3,000 mg a day
- Increase by 500 mg twice daily every 2 weeks to a recommended dose of 1,500 mg twice daily
Keppra is a brand name for this medicine. See Keppra’s full dosing instructions on DailyMed →
Children 1 month to less than 6 months old · Keppra 7 mg/kg Starting dose 7 mg/kg twice a day Usual dose 21 mg/kg twice a day
- Increase by 7 mg/kg twice daily every 2 weeks to recommended dose of 21 mg/kg twice daily
Keppra is a brand name for this medicine. See Keppra’s full dosing instructions on DailyMed →
Children 6 months to less than 4 years old · Keppra 10 mg/kg Starting dose 10 mg/kg twice a day Usual dose 25 mg/kg twice a day
- Increase by 10 mg/kg twice daily every 2 weeks to recommended dose of 25 mg/kg twice daily
Keppra is a brand name for this medicine. See Keppra’s full dosing instructions on DailyMed →
Children 4 to less than 16 years old · Keppra 10 mg/kg Starting dose 10 mg/kg twice a day Usual dose 30 mg/kg twice a day
- Increase by 10 mg/kg twice daily every 2 weeks to recommended dose of 30 mg/kg twice daily
Keppra is a brand name for this medicine. See Keppra’s full dosing instructions on DailyMed →
Myoclonic seizures in juvenile myoclonic epilepsy
Adults Starting dose 500 mg twice a day Usual dose 1,500 mg twice a day
- Increase by 500 mg twice daily every 2 weeks to the recommended dose of 1,500 mg twice daily
Adults and children 12 years and older · Keppra 500 mg Starting dose 500 mg twice a day Usual dose 1,500 mg twice a day
- Increase by 500 mg twice daily every 2 weeks to recommended dose of 1,500 mg twice daily
Keppra is a brand name for this medicine. See Keppra’s full dosing instructions on DailyMed →
Primary generalized tonic-clonic seizures
Adults Starting dose 500 mg twice a day Usual dose 1,500 mg twice a day
- Increase by 500 mg twice daily every 2 weeks to the recommended dose of 1,500 mg twice daily
Adults 16 years and older · Keppra 500 mg Starting dose 500 mg twice a day Usual dose 1,500 mg twice a day
- Increase by 500 mg twice daily every 2 weeks to recommended dose of 1,500 mg twice daily
Keppra is a brand name for this medicine. See Keppra’s full dosing instructions on DailyMed →
Children 6 to less than 16 years old · Keppra 10 mg/kg Starting dose 10 mg/kg twice a day Usual dose 30 mg/kg twice a day
- Increase by 10 mg/kg twice daily every 2 weeks to recommended dose of 30 mg/kg twice daily
Keppra is a brand name for this medicine. See Keppra’s full dosing instructions on DailyMed →
Injection, with normal kidney function (CLcr > 80)
For adults
Dose 500 to 1,500 mg every 12 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Injection, with mild kidney problems (CLcr 50 – 80)
For adults
Dose 500 to 1,000 mg every 12 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Injection, with moderate kidney problems (CLcr 30 – 50)
For adults
Dose 250 to 750 mg every 12 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Injection, with severe kidney problems (CLcr < 30)
For adults
Dose 250 to 500 mg every 12 hours
CrCl means creatinine clearance, a measure of how well the kidneys work.
Side Effects
Many side effects show up early, often in the first month.
Common side effects
- Sleepiness (somnolence)
- Weakness or tiredness (asthenia, fatigue)
- Dizziness
- Infections
- Headache
- In children: aggression, irritability, decreased appetite, nasal congestion
- Coordination problems
When to get medical help
- Call your doctor right away for new or worsening depression, suicidal thoughts, or unusual mood or behavior changes.
- Get help for hallucinations, paranoia, confusion, or severe agitation or aggression.
- Seek emergency care for swelling of the face, lips, tongue or throat, hives, or trouble breathing (anaphylaxis or angioedema).
- Stop and call your doctor at the first sign of a rash, which can signal a serious skin reaction such as Stevens-Johnson syndrome.
- Get evaluated right away for fever, swollen glands, rash or facial swelling, which may signal DRESS (a serious multiorgan allergic reaction).
- Tell your doctor about significant weakness, fever, or repeated infections, since blood counts can drop.
- Report unsteadiness, trouble walking, or poor coordination.
Warnings and Precautions
- Suicidal thoughts and behavior: antiepileptic drugs raise this risk slightly. Watch for new or worsening depression or mood changes.
- Behavior and psychotic symptoms: aggression, irritability, paranoia or hallucinations can occur, especially in children.
- Sleepiness and coordination problems: avoid driving until you know how it affects you.
- Allergic and skin reactions: anaphylaxis, angioedema, Stevens-Johnson syndrome and DRESS have been reported. Stop and get help at the first sign of rash or swelling.
- Blood count changes: report significant weakness, fever or repeated infections.
- Stopping suddenly: can increase seizures. It is usually withdrawn gradually.
Interactions
Levetiracetam has few drug interactions.
- Other antiepileptic drugs such as phenytoin, valproate, carbamazepine and lamotrigine did not change levetiracetam levels, nor did it change theirs.
- Birth control pills: no effect on their action was seen.
- Warfarin and digoxin: no effect was seen.
- Probenecid: raised levels of an inactive breakdown product only.
Interactions Listed in the FDA-Approved Label
From the Levetiracetam prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
What happensLevetiracetam did not affect phenytoin pharmacokinetics, and phenytoin did not affect levetiracetam.
-
ValproateWhat happensNeither levetiracetam nor valproate changed the other's pharmacokinetics.
-
Other antiepileptic drugs (carbamazepine, gabapentin, lamotrigine, phenobarbital, primidone, topiramate)What happensLevetiracetam does not influence the plasma concentration of other AEDs and they do not influence levetiracetam.
-
Enzyme-inducing antiepileptic drugs in childrenWhat happensAbout a 22% increase of apparent total body clearance of levetiracetam when co-administered.What to doDose adjustment is not recommended.
-
Oral contraceptivesWhat happensLevetiracetam did not influence the pharmacokinetics of an oral contraceptive; impairment of contraceptive efficacy is unlikely.
-
What happensLevetiracetam did not influence the pharmacokinetics and pharmacodynamics of digoxin, and digoxin did not influence levetiracetam.
-
What happensLevetiracetam did not influence the pharmacokinetics of R and S warfarin; prothrombin time was not affected.
-
What happensProbenecid did not change levetiracetam pharmacokinetics, but approximately doubled Css max of metabolite ucb L057 and decreased its renal clearance 60%.
Read the label’s full interactions text
Drug Interactions In vitro data on metabolic interactions indicate that levetiracetam is unlikely to produce, or be subject to, pharmacokinetic interactions. Levetiracetam and its major metabolite, at concentrations well above C max levels achieved within the therapeutic dose range, are neither inhibitors of, nor high affinity substrates for, human liver cytochrome P450 isoforms, epoxide hydrolase or UDP-glucuronidation enzymes. In addition, levetiracetam does not affect the in vitro glucuronidation of valproic acid. Potential pharmacokinetic interactions of or with levetiracetam were assessed in clinical pharmacokinetic studies (phenytoin, valproate, warfarin, digoxin, oral contraceptive, probenecid) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients. Phenytoin Levetiracetam (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy. Pharmacokinetics of levetiracetam were also not affected by phenytoin. Valproate Levetiracetam (1500 mg twice daily) did not alter the pharmacokinetics of valproate in healthy volunteers. Valproate 500 mg twice daily did not modify the rate or extent of levetiracetam absorption or its plasma clearance or urinary excretion. There also was no effect on exposure to and the excretion of the primary metabolite, ucb L057. Other Antiepileptic Drugs Potential drug interactions between levetiracetam and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies. These data indicate that levetiracetam does not influence the plasma concentration of other AEDs and that these AEDs do not influence the pharmacokinetics of levetiracetam.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Don't use it if you have had a severe allergic reaction to levetiracetam.
- Kidney problems: the dose may need adjusting, and extra doses may be needed after dialysis.
- Pregnancy: blood levels can fall, so your doctor may monitor you closely. A pregnancy registry is available.
- Breastfeeding: it passes into breast milk, so discuss it with your doctor.
- Children: age and weight limits vary by product.
- Older adults: kidney function may be reduced, so dosing needs care.
Overdose
Overdose can cause drowsiness, agitation, aggression, reduced alertness, slowed breathing and coma. There is no specific antidote. Supportive care is given, and hemodialysis can remove a significant amount of the drug. Contact Poison Control or seek emergency help.
Half-Life and How Your Body Processes It
Levetiracetam is absorbed rapidly and almost completely by mouth. The injection and tablets deliver equivalent exposure. Its half-life is about 6 to 8 hours, and longer in older adults and people with kidney problems. About two-thirds of a dose is cleared by the kidneys unchanged. It isn't broken down by liver cytochrome P450 enzymes and binds very little to proteins.
Storage
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) .
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Levetiracetam
From the licensed clinical database we use, rolled up per supplement, most serious first.104 supplements and herbal products have documented interactions with Levetiracetam in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 7Major
- 81Moderate
- 16Minor
- 1,4-BUTANEDIOLMajor
- ACTIVATED CHARCOALMajor
- BEERMajor
- GAMMA-HYDROXYBUTYRATE (GHB)Major
- KAVAMajor
- L-TRYPTOPHANMajor
- WINEMajor
- 5-HTPModerate
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrients Levetiracetam May Deplete
Nutrients Levetiracetam has been linked with lower levels of, from the licensed clinical database we use.Levetiracetam has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur. It means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines), not medical advice. Do not start or stop medications or supplements without professional guidance.
Levetiracetam: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Levetiracetam — the kind of thing our pharmacy team would talk through with you at the counter.
What is levetiracetam used for?
Can I stop taking levetiracetam suddenly?
Will levetiracetam make me sleepy, and can I drive?
What mood side effects should I watch for?
Does levetiracetam interact with other medicines or birth control?
Is levetiracetam safe in pregnancy?
Is levetiracetam available over the counter?
When was levetiracetam first available?
Who makes levetiracetam?
What is the brand name of levetiracetam?
What is the generic name of Elepsia XR?
Is there a generic version of levetiracetam?
What strengths does levetiracetam come in?
How much does levetiracetam cost?
Is there a levetiracetam shortage?
Where can I read the levetiracetam prescribing information (package insert)?
Can you crush levetiracetam?
Is levetiracetam gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Levetiracetam
Skip the scrolling. Ask in your own words and get an answer from Levetiracetam’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Levetiracetam’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Levetiracetam on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, usually within a day.Levetiracetam Forms and Strengths (How It Comes)
Levetiracetam comes in 4 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Levetiracetam inactive ingredients by manufacturer.
Tablet
How this form is used
- Keppra and Roweepra tablets are used for partial-onset seizures from 1 month of age, plus add-on use for myoclonic and generalized tonic-clonic seizures.
- Spritam is used for partial-onset seizures in patients 4 and older weighing more than 20 kg, plus add-on use for myoclonic and generalized tonic-clonic seizures.
- Spritam is meant to disintegrate in the mouth with a sip of liquid and is not swallowed whole.
- Spritam can also be dispersed in a small amount of liquid and taken right away, or given through a feeding tube.
- Partial Spritam tablets should not be given.
Injection
How this form is used
- Keppra injection and Levetiracetam injection are for use only when oral administration is temporarily not feasible.
- Levetiracetam in Sodium Chloride injection is add-on therapy for adults 16 and older with partial-onset, myoclonic or primary generalized tonic-clonic seizures.
- Keppra injection is for intravenous use only.
- Levetiracetam in Sodium Chloride injection is for intravenous infusion over 15 minutes and should not be diluted before use.
Show 2 more strengths Show fewer strengths
Extended-release tablet
How this form is used
- Keppra XR and Levetiracetam ER are used for partial-onset seizures in patients 12 and older.
- Elepsia XR is add-on therapy for partial-onset seizures in patients 12 and older.
- Keppra XR and Levetiracetam ER are taken once daily and swallowed whole, not chewed, broken or crushed.
- Elepsia XR is taken once daily and should be taken whole, not split or cut.
- Elepsia XR is not recommended for moderate or severe kidney impairment.
Oral solution
How this form is used
- Keppra oral solution is used for partial-onset seizures from 1 month of age, with add-on use for myoclonic and generalized tonic-clonic seizures at older ages.
- Levetiracetam oral solution is used for children weighing 20 kg or less.
- For children, measure with a calibrated device, not a household teaspoon or tablespoon.
Levetiracetam on the U.S. Market: Products, Makers and Brands
How Levetiracetam appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
84 companies list 304 Levetiracetam product records with the FDA, mostly as tablet, injection, extended-release tablet; the earliest marketing or approval year on record is 1999. Brand names in the directory today include Keppra, Keppra XR, Spritam and 1 more; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (33) · Unfinished tablet, film coated (11) · Unfinished tablet, film coated, extended release (2) · Unfinished injection, solution, concentrate (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Levetiracetam Is Used (Medicaid Data)
How many Levetiracetam prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Levetiracetam prescribed? Of the 1,682 medications we measure, Levetiracetam ranks #73 by Medicaid prescriptions — more than 96% of them.
Utilization by Levetiracetam product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
levetiracetam 500 MG Oral Tablet Most dispensed
27 of 194 listed NDCs had Medicaid claims. RxNorm 311289
levetiracetam 100 MG/ML Oral Solution
12 of 121 listed NDCs had Medicaid claims. RxNorm 403884
levetiracetam 1000 MG Oral Tablet
16 of 99 listed NDCs had Medicaid claims. RxNorm 387003
levetiracetam 750 MG Oral Tablet
23 of 96 listed NDCs had Medicaid claims. RxNorm 311290
levetiracetam 250 MG Oral Tablet
22 of 113 listed NDCs had Medicaid claims. RxNorm 311288
24 HR levetiracetam 500 MG Extended Release Oral Tablet
7 of 50 listed NDCs had Medicaid claims. RxNorm 807832
24 HR levetiracetam 750 MG Extended Release Oral Tablet
8 of 36 listed NDCs had Medicaid claims. RxNorm 846378
5 ML levetiracetam 100 MG/ML Injection
19 of 50 listed NDCs had Medicaid claims. RxNorm 647121
100 ML levetiracetam 10 MG/ML Injection
9 of 30 listed NDCs had Medicaid claims. RxNorm 1193358
100 ML levetiracetam 15 MG/ML Injection
8 of 28 listed NDCs had Medicaid claims. RxNorm 1193360
100 ML levetiracetam 5 MG/ML Injection
7 of 30 listed NDCs had Medicaid claims. RxNorm 1193362
levetiracetam 500 MG Tablet for Oral Suspension
1 of 5 listed NDCs had Medicaid claims. RxNorm 1736048
levetiracetam 1000 MG Tablet for Oral Suspension
1 of 2 listed NDCs had Medicaid claims. RxNorm 1736037
levetiracetam 250 MG Tablet for Oral Suspension
1 of 6 listed NDCs had Medicaid claims. RxNorm 1736045
levetiracetam 750 MG Tablet for Oral Suspension
1 of 2 listed NDCs had Medicaid claims. RxNorm 1736051
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 162 of the 862 listed Levetiracetam NDCs had Medicaid claims.
Compare Levetiracetam Products
A representative set of FDA-listed product records for Levetiracetam — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Extended-release tablet | ||||
| 500 mg | Oral | Apotex Corp. | ANDA | View NDC → |
| 750 mg | Oral | Apotex Corp. | ANDA | View NDC → |
| 1000 mg | Oral | Apotex Corp. | ANDA | View NDC → |
| 500 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 750 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 500 mg | Oral | Bryant Ranch Prepack | ANDA | View NDC → |
| 500 mg | Oral | Direct_Rx | ANDA | View NDC → |
| 500 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 750 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 750 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Omnivium Pharmaceuticals LLC | ANDA | View NDC → |
| 750 mg | Oral | Omnivium Pharmaceuticals LLC | ANDA | View NDC → |
| 500 mg | Oral | Proficient Rx LP × 2 listings | ANDA | View NDC → |
| 750 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 500 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 750 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 500 mg | Oral | ScieGen Pharmaceuticals, Inc | ANDA | View NDC → |
| 750 mg | Oral | ScieGen Pharmaceuticals, Inc | ANDA | View NDC → |
| 500 mg | Oral | Solco healthcare U.S., LLC | ANDA | View NDC → |
| 750 mg | Oral | Solco healthcare U.S., LLC | ANDA | View NDC → |
| 500 mg | Oral | Torrent Pharmaceuticals Limited | ANDA | View NDC → |
| 750 mg | Oral | Torrent Pharmaceuticals Limited | ANDA | View NDC → |
| 1000 mg | Oral | Tripoint Therapeutics, Llc | NDA | View NDC → |
| 1500 mg | Oral | Tripoint Therapeutics, Llc | NDA | View NDC → |
| 500 mg | Oral | UCB, Inc. | NDA | View NDC → |
| 750 mg | Oral | UCB, Inc. | NDA | View NDC → |
| 500 mg | Oral | Westminster Pharmaceuticals, LLC | ANDA | View NDC → |
| 750 mg | Oral | Westminster Pharmaceuticals, LLC | ANDA | View NDC → |
| 💊Injection | ||||
| 100 mg/mL | Intravenous | Armas Pharmaceuticals Inc. | ANDA | View NDC → |
| 500 mg/5 mL | Intravenous | Aryeh Pharma corp | ANDA | View NDC → |
| 5 mg/mL | Intravenous | B. Braun Medical Inc. | ANDA | View NDC → |
| 10 mg/mL | Intravenous | B. Braun Medical Inc. | ANDA | View NDC → |
| 15 mg/mL | Intravenous | B. Braun Medical Inc. | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Baxter Healthcare Corporation | ANDA | View NDC → |
| 10 mg/mL | Intravenous | Baxter Healthcare Corporation | ANDA | View NDC → |
| 15 mg/mL | Intravenous | Baxter Healthcare Corporation | ANDA | View NDC → |
| 500 mg/5 mL | Intravenous | Bryant Ranch Prepack | ANDA | View NDC → |
| 500 mg/100 mL | Intravenous | Caplin Steriles Limited | ANDA | View NDC → |
| 1000 mg/100 mL | Intravenous | Caplin Steriles Limited | ANDA | View NDC → |
| 1500 mg/100 mL | Intravenous | Caplin Steriles Limited | ANDA | View NDC → |
| 100 mg/mL | Intravenous | Civica, Inc. | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Dr.Reddy's Laboratories Inc × 2 listings | ANDA | View NDC → |
| 10 mg/mL | Intravenous | Dr.Reddy's Laboratories Inc | ANDA | View NDC → |
| 500 mg/5 mL | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 500 mg/100 mL | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 1000 mg/100 mL | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 10 mg/mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 15 mg/mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 10 mg/mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 15 mg/mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 10 mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 15 mg/mL | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 100 mg/mL | Intravenous | Hospira, Inc. × 2 listings | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Hp Halden Pharma AS | ANDA | View NDC → |
| 10 mg/mL | Intravenous | Hp Halden Pharma AS | ANDA | View NDC → |
| 15 mg/mL | Intravenous | Hp Halden Pharma AS | ANDA | View NDC → |
| 500 mg/5 mL | Intravenous | Method Pharmaceuticals, LLC | ANDA | View NDC → |
| 100 mg/mL | Intravenous | Micro Labs Limited | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Mylan Institutional LLC | NDA | View NDC → |
| 10 mg/mL | Intravenous | Mylan Institutional LLC | NDA | View NDC → |
| 15 mg/mL | Intravenous | Mylan Institutional LLC | NDA | View NDC → |
| 5 mg/mL | Intravenous | Nexus Pharmaceuticals LLC | ANDA | View NDC → |
| 10 mg/mL | Intravenous | Nexus Pharmaceuticals LLC | ANDA | View NDC → |
| 15 mg/mL | Intravenous | Nexus Pharmaceuticals LLC | ANDA | View NDC → |
| 500 mg/5 mL | Intravenous | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 100 mg/mL | Intravenous | Precision Dose, Inc. | ANDA | View NDC → |
| 5 mg/mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 10 mg/mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 15 mg/mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 500 mg/5 mL | Intravenous | Solco Healthcare US, LLC | ANDA | View NDC → |
| 500 mg/100 mL | Intravenous | Somerset Therapeutics, LLC | ANDA | View NDC → |
| 1000 mg/100 mL | Intravenous | Somerset Therapeutics, LLC | ANDA | View NDC → |
| 1500 mg/100 mL | Intravenous | Somerset Therapeutics, LLC | ANDA | View NDC → |
| 100 mg/mL | Intravenous | TAGI Pharma, Inc. | ANDA | View NDC → |
| 100 mg/mL | Intravenous | UCB, Inc. | NDA | View NDC → |
| 5 mg/mL | Intravenous | WG Critical Care, LLC | NDA | View NDC → |
| 10 mg/mL | Intravenous | WG Critical Care, LLC | NDA | View NDC → |
| 15 mg/mL | Intravenous | WG Critical Care, LLC | NDA | View NDC → |
| 500 mg/5 mL | Intravenous | XGen Pharmaceuticals DJB, Inc. | ANDA | View NDC → |
| 💊Oral solution | ||||
| 100 mg/mL | Oral | Actavis Pharma, Inc. | ANDA | View NDC → |
| 100 mg/mL | Oral | American Health Packaging | ANDA | View NDC → |
| 100 mg/mL | Oral | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 100 mg/mL | Oral | Atlantic Biologicals Corp. | ANDA | View NDC → |
| 100 mg/mL | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 100 mg/mL | Oral | Bionpharma Inc. | ANDA | View NDC → |
| 100 mg/mL | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 100 mg/mL | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 100 mg/mL | Oral | Cardinal Health 107, LLC | ANDA | View NDC → |
| 500 mg/5 mL | Oral | Cardinal Health 107, LLC | ANDA | View NDC → |
| 100 mg/mL | Oral | Chartwell Governmental & Specialty RX, LLC. | ANDA | View NDC → |
| 100 mg/mL | Oral | Chartwell RX, LLC | ANDA | View NDC → |
| 100 mg/mL | Oral | Guardian Drug Company | ANDA | View NDC → |
| 100 mg/mL | Oral | Kesin Pharma Corporation | ANDA | View NDC → |
| 100 mg/mL | Oral | Major Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 100 mg/mL | Oral | Natco Pharma USA LLC | ANDA | View NDC → |
| 100 mg/mL | Oral | NorthStar Rx LLC | ANDA | View NDC → |
| 100 mg/mL | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 100 mg/mL | Oral | PAI Holdings, LLC dba PAI Pharma | ANDA | View NDC → |
| 500 mg/5 mL | Oral | PAI Holdings, LLC dba PAI Pharma | ANDA | View NDC → |
| 100 mg/mL | Oral | Patrin Pharma, Inc. | ANDA | View NDC → |
| 100 mg/mL | Oral | Quagen Pharmaceuticals Llc | ANDA | View NDC → |
| 100 mg/mL | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 100 mg/mL | Oral | Sun Pharmaceutical Industries, Inc. | ANDA | View NDC → |
| 100 mg/mL | Oral | UCB, Inc. | NDA | View NDC → |
| 💊Tablet | ||||
| 250 mg | Oral | A-S Medication Solutions | ANDA | View NDC → |
| 500 mg | Oral | A-S Medication Solutions | ANDA | View NDC → |
| 500 mg | Oral | Advanced Rx of Tennessee, LLC × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 500 mg | Oral | American Health Packaging | ANDA | View NDC → |
| 250 mg | Oral | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 500 mg | Oral | Amneal Pharmaceuticals LLC | ANDA | View NDC → |
| 250 mg | Oral | Aprecia Pharmaceuticals, LLC | NDA | View NDC → |
| 500 mg | Oral | Aprecia Pharmaceuticals, LLC | NDA | View NDC → |
| 250 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| 500 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| 250 mg | Oral | Asclemed Usa Inc. | ANDA | View NDC → |
| 500 mg | Oral | Asclemed Usa Inc. | ANDA | View NDC → |
| 250 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 500 mg | Oral | Aurobindo Pharma Limited | ANDA | View NDC → |
| 250 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 500 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 250 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 250 mg | Oral | Cardinal Health 107, LLC | ANDA | View NDC → |
| 500 mg | Oral | Cardinal Health 107, LLC | ANDA | View NDC → |
| 250 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 500 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 250 mg | Oral | Cranbury Pharmaceuticals, LLC | ANDA | View NDC → |
| 500 mg | Oral | Cranbury Pharmaceuticals, LLC | ANDA | View NDC → |
| 250 mg | Oral | Direct Rx | ANDA | View NDC → |
| 500 mg | Oral | Direct Rx | ANDA | View NDC → |
| 250 mg | Oral | Direct_Rx | ANDA | View NDC → |
| 1000 mg | Oral | Direct_Rx | ANDA | View NDC → |
| 250 mg | Oral | Dr. Reddy's Laboratories Limited | ANDA | View NDC → |
| 500 mg | Oral | Dr. Reddy's Laboratories Limited | ANDA | View NDC → |
| 250 mg | Oral | Exelan Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Exelan Pharmaceuticals, Inc. | ANDA | View NDC → |
| 250 mg | Oral | Granules Pharmaceuticals Inc. | ANDA | View NDC → |
| 500 mg | Oral | Granules Pharmaceuticals Inc. | ANDA | View NDC → |
| 500 mg | Oral | Injecta Medcial LLC | ANDA | View NDC → |
| 250 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 250 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 500 mg | Oral | Major Pharmaceuticals | ANDA | View NDC → |
| 500 mg | Oral | Mylan Institutional Inc. | ANDA | View NDC → |
| 500 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 750 mg | Oral | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 250 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | View NDC → |
| 500 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | View NDC → |
| 250 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 500 mg | Oral | NorthStar RxLLC | ANDA | View NDC → |
| 500 mg | Oral | Northwind Health Company, LLC | ANDA | View NDC → |
| 250 mg | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 500 mg | Oral | Novadoz Pharmaceuticals LLC | ANDA | View NDC → |
| 250 mg | Oral | OWP Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg | Oral | OWP Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| 500 mg | Oral | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| 250 mg | Oral | Preferred Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Preferred Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 250 mg | Oral | Prinston Pharmaceutical Inc. | ANDA | View NDC → |
| 500 mg | Oral | Prinston Pharmaceutical Inc. | ANDA | View NDC → |
| 500 mg | Oral | Proficient Rx LP | ANDA | View NDC → |
| 250 mg | Oral | Quallent Pharmaceuticals Health LLC | ANDA | View NDC → |
| 500 mg | Oral | Quallent Pharmaceuticals Health LLC | ANDA | View NDC → |
| 250 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 500 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 250 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Rising Pharma Holdings, Inc. | ANDA | View NDC → |
| 500 mg | Oral | Safecor Health LLC | ANDA | View NDC → |
| 250 mg | Oral | ScieGen Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg | Oral | ScieGen Pharmaceuticals, Inc. | ANDA | View NDC → |
| 250 mg | Oral | SOHM, Inc. | ANDA | View NDC → |
| 500 mg | Oral | SOHM, Inc. | ANDA | View NDC → |
| 250 mg | Oral | Solco Healthcare US, LLC × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Torrent Pharmaceuticals Limited | ANDA | View NDC → |
| 500 mg | Oral | Torrent Pharmaceuticals Limited | ANDA | View NDC → |
| 250 mg | Oral | UCB, Inc. | NDA | View NDC → |
| 500 mg | Oral | UCB, Inc. | NDA | View NDC → |
| 500 mg | Oral | Unit Dose Solutions, Inc. | ANDA | View NDC → |
| 250 mg | Oral | XLCare Pharmaceuticals Inc. | ANDA | View NDC → |
| 500 mg | Oral | XLCare Pharmaceuticals Inc. | ANDA | View NDC → |
Showing 200 of 304 products — FDA National Drug Code Directory. See every product, package size and price: browse all 304 Levetiracetam NDCs →
Levetiracetam Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Levetiracetam — a signal of what to watch for, not proof the drug caused it.
The effects most often named in FDA reports that mention Levetiracetam are seizure, fatigue, somnolence; about 83% of the reports were classed as serious. These are voluntary reports, so they show what people report, not how often it happens.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Levetiracetam in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Levetiracetam FDA Approval History
How Levetiracetam went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Levetiracetam was first approved by the FDA in 1999 (Brand: KEPPRA · Ucb Inc); the first generic version was approved in 2008. It remains available in U.S. pharmacies today.
Source: Drugs@FDA.
Levetiracetam Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list one Levetiracetam recall since July 2021. It is still ongoing. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Levetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, Manufactured by: Gland Pharma Limited, Hyderabad, - 500 043 INDIA, Distributor: Dr. Reddy's Laboratori… Lots: Lot: A1540076, Exp 08/31/2026 FDA record D-0365-2025 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Levetiracetam in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 5
- Strengths
- 18
- Forms in current FDA listings
- 5 of 5
RxCUI 114477 -
Dose form (SCDF) InjectionIn current FDA listings
RxCUI 1790330Its 5 strengths (SCD)-
5 mL levetiracetam 100 mg/mL
RxCUI 647121 -
50 mL levetiracetam 5 mg/mL
RxCUI 2585478 -
100 mL levetiracetam 10 mg/mL
RxCUI 1193358 -
100 mL levetiracetam 15 mg/mL
RxCUI 1193360 -
100 mL levetiracetam 5 mg/mL
RxCUI 1193362
-
5 mL levetiracetam 100 mg/mL
-
Dose form (SCDF) Oral SolutionIn current FDA listings
RxCUI 406121Its strength (SCD)-
100 mg/mL
RxCUI 403884
-
100 mg/mL
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Levetiracetam Supply and Shortage Status
Whether Levetiracetam is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Levetiracetam Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Levetiracetam: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
No national price was found for Levetiracetam injections, so the prices below are for the tablets, extended-release tablets and oral solution only.
How the Pharmacy Price Has Changed
Pick a form, the generic or the brand, and a strength to see how its price has changed since Nov 2023.
The brands at this strength: Keppra $8.08 and Spritam $10.27 per tablet.
For the generic 250 mg tablet, pharmacies paid an average of $0.057 per tablet as of Nov 18, 2026, down 4.9% from $0.060 a year earlier. The brands at this strength: Keppra $8.08 and Spritam $10.27 per tablet.
- What pharmacies pay now
- $0.057
- per tablet, as of Nov 18, 2026
- Last 4 weeks
- Up 0.4%
- from $0.057 on Oct 21, 2026
- Last 12 months
- Down 4.9%
- from $0.060 on Nov 19, 2025
- Lowest and highest since Nov 2023
- $0.045 to $0.074
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $0.057 |
| Oct 2026 | $0.057 |
| Sep 2026 | $0.056 |
| Aug 2026 | $0.058 |
| Jul 2026 | $0.059 |
| Jun 2026 | $0.060 |
| May 2026 | $0.059 |
| Apr 2026 | $0.058 |
| Mar 2026 | $0.056 |
| Feb 2026 | $0.057 |
| Jan 2026 | $0.059 |
| Dec 2025 | $0.061 |
| Nov 2025 | $0.060 |
| Oct 2025 | $0.059 |
| Sep 2025 | $0.060 |
| Aug 2025 | $0.063 |
| Jul 2025 | $0.063 |
| Jun 2025 | $0.064 |
| May 2025 | $0.061 |
| Apr 2025 | $0.060 |
| Mar 2025 | $0.061 |
| Feb 2025 | $0.057 |
| Jan 2025 | $0.053 |
| Dec 2024 | $0.051 |
| Nov 2024 | $0.045 |
| Oct 2024 | $0.061 |
| Sep 2024 | $0.063 |
| Aug 2024 | $0.065 |
| Jul 2024 | $0.049 |
| Jun 2024 | $0.067 |
| May 2024 | $0.051 |
| Apr 2024 | $0.055 |
| Mar 2024 | $0.063 |
| Feb 2024 | $0.064 |
| Jan 2024 | $0.065 |
| Dec 2023 | $0.070 |
| Nov 2023 | $0.074 |
See all 15 prices in a table
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Tablet · Oral | 250 mg | Generic | $0.057 per tablet | NDC details & price history |
| Tablet · Oral | 250 mg | Keppra (brand) | $8.08 per tablet | NDC details & price history |
| Tablet · Oral | 250 mg | Spritam (brand) | $10.27 per tablet | NDC details & price history |
| Tablet · Oral | 500 mg | Generic | $0.073 per tablet | NDC details & price history |
| Tablet · Oral | 500 mg | Keppra (brand) | $9.91 per tablet | NDC details & price history |
| Tablet · Oral | 500 mg | Spritam (brand) | $10.24 per tablet | NDC details & price history |
| Tablet · Oral | 750 mg | Generic | $0.116 per tablet | NDC details & price history |
| Tablet · Oral | 1000 mg | Generic | $0.167 per tablet | NDC details & price history |
| Tablet · Oral | 1000 mg | Spritam (brand) | $10.20 per tablet | NDC details & price history |
| Extended-release tablet · Oral | 500 mg | Generic | $0.182 per tablet | NDC details & price history |
| Extended-release tablet · Oral | 500 mg | Keppra (brand) | $9.00 per tablet | NDC details & price history |
| Extended-release tablet · Oral | 750 mg | Generic | $0.250 per tablet | NDC details & price history |
| Extended-release tablet · Oral | 750 mg | Keppra (brand) | $13.48 per tablet | NDC details & price history |
| Oral solution · Oral | 100 mg/mL | Generic | $0.030 per mL | NDC details & price history |
| Oral solution · Oral | 100 mg/mL | Keppra (brand) | $1.92 per mL | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Levetiracetam Brand Names
Levetiracetam has 5 brand names on record: Elepsia XR, Keppra, Keppra XR, Spritam and others. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Levetiracetam: Manufacturers and Labelers
84 companies list Levetiracetam products with the FDA. By number of product records, the largest are A-S Medication Solutions, Bryant Ranch Prepack, Remedyrepack Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 60 more on the FDA NDC directory.
Sources for This Levetiracetam Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. UCB, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →